Top

Current Bladder Dysfunction Reports

Published in:

01-12-2020 | Overactive Bladder | Overactive Bladder (U Lee and S Adelstein, Section Editors)

Treatment of Overactive Bladder in the Frail Patient

Authors: Sage Vincent, Anthony Tokarski, Alana Murphy

Published in: Current Bladder Dysfunction Reports | Issue 4/2020

Abstract

Purpose of Review

To understand how frailty interacts with overactive bladder. To explore how frailty should be considered when devising an individualized treatment plan for OAB patients.

Recent Findings

Frailty can be assessed in the outpatient office without undue burden. The urology community is increasingly aware of the importance of evaluating a patient for frailty and including this assessment in treatment algorithms. Frailty should be considered when treating OAB patients, since frail OAB patients are more susceptible to the potential deleterious consequences of medical therapy, onabotulinumtoxinA therapy, and sacral neuromodulation.

Summary

A patient’s frailty status should be considered during counseling regarding OAB therapy. Additional studies are needed to examine the treatment effects and risks in the frail OAB population.

Cardona-Grau D, Spettel S. History of the term “overactive bladder”. Curr Bladder Dysfunct Rep. 2014;9:48–51. https://doi.org/10.1007/s11884-013-0218-3.CrossRef

Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (AUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20. https://doi.org/10.1002/nau.20798.CrossRefPubMed

Ninomiya S, Naito K, Nakanishi K, Okayama H. Prevalence and risk factors of urinary incontinence and overactive bladder in Japanese women. Low Urin Tract Symptoms. 2018;10(3):308–14. https://doi.org/10.1111/luts.12185.CrossRefPubMed

Kim DY, Jang DH, Kim HJ, Lee SR, Jeon MJ, Shin JH, et al. A multicenter cross-sectional study on the prevalence of overactive bladder and its impacts on the quality of life in gynecologic outpatients. Obstet Gynecol Sci. 2020;63:181–6. https://doi.org/10.5468/ogs.2020.63.2.181.CrossRefPubMedPubMedCentral

Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306–15. https://doi.org/10.1016/j.eururo.2006.09.019.CrossRefPubMed

Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327–36. https://doi.org/10.1007/s00345-002-0301-4.CrossRefPubMed

Coyne KS, Sexton CC, Clemens JQ, Thompson CL, Chen C, Bavendam T, et al. The impact of OAB on physical activity in the United States: results from OAB-POLL. Urology. 2013;82:799–806. https://doi.org/10.1016/j.urology.2013.05.035.CrossRefPubMed

Kinsey D, Pretorius S, Glover L, Alexander T. The psychological impact of overactive bladder: a systematic review. J Health Psychol. 2016;21:69–81. https://doi.org/10.1177/1359105314522084.CrossRefPubMed

Coyne KS, Sexton CC, Thompson CL, Clemens JQ, Chen C, Bavendam T, et al. Impact of overactive bladder on work productivity. Urology. 2012;80:97–103. https://doi.org/10.1016/j.urology.2012.03.039.CrossRefPubMed

10.

Milson I, Kaplan SA, Conyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression and treatment seeking in the United States: results from EpiLUTS. Urology. 2012;80:90–6. https://doi.org/10.1016/j.urology.2012.04.004.CrossRef

11.

Reynolds WS, Fowke J, Dmochowski R. The burden of overactive bladder on US public health. Curr Bladder Dysfunct Rep. 2016;11:8–13. https://doi.org/10.1007/s11884-016-0344-9.CrossRefPubMedPubMedCentral

12.

Suskind AM, Walter LC, Jin C, Boscardin J, Sen S, Cooperberg MR, et al. Impact of frailty on complications in patients undergoing common urological procedures: a study from the American College of Surgeons National Surgical Quality Improvement database. BJU Int. 2016;117:836–42. https://doi.org/10.1111/bju.13399.CrossRefPubMedPubMedCentral

13.

•• Suskind AM, Zhao S, Walter LC, Boscardin JW, Finlayson E. Mortality and functional outcomes after minor urologic surgery among nursing home residents: a national study. J Am Geriatr Soc. 2018;66:909–15. https://doi.org/10.1111/jgs.15302This retrospective cohort study demonstrated significant functional impairment and mortality rates in elderly, nursing home patients following simple urologic surgeries, which was previously not quantified. Authors concluded that this is a vulnerable population requiring improved treatment decision making processes.CrossRefPubMedPubMedCentral

14.

Gormley EA, Lightner DJ, Faraday M, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015;193:1572–80. https://doi.org/10.1016/j.uro.2015.01.087.CrossRefPubMed

15.

Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, et al. Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score. Urology. 2006;68:318–23. https://doi.org/10.1016/j.urology.2006.02.042.CrossRefPubMed

16.

Chow WB, Rosenthal RA, Merkow RP, Yo CY, Esnaola NF. Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society. J Am Coll Surg. 2012;215:453–66. https://doi.org/10.1016/j.jamcollsurg.2012.06.017.CrossRefPubMed

17.

Saklad M. Grading of patients for surgical procedures. Anesthesiology. 1941;2:281–4.CrossRef

18.

Hackett NJ, De Oliveira GS, Jain UK, Kim JYS. ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int J Surg. 2015;18:184–90. https://doi.org/10.1016/j.ijsu.2015.04.079.CrossRefPubMed

19.

Amin KA, Lee UJ, Jin C, Boscardin J, Medendorp AR, Anger JT, et al. A national study demonstrating the need for improved frailty indices for preoperative risk assessment of common urologic procedures. Urology. 2019;132:87–93. https://doi.org/10.1016/j.urology.2019.07.001.CrossRefPubMedPubMedCentral

20.

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Scie Med Sci. 2001;56:M146–57. https://doi.org/10.1093/gerona/56.3.m146.CrossRef

21.

Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–8. https://doi.org/10.1111/j.1532-5415.1991.tb01616.x.CrossRefPubMed

22.

• Pangilinan J, Quanstrom K, Bridge M, Walter LC, Finlyason E, Suskind AM. The Timed Up and Go Test as a measure of frailty in urologic practice. Urology. 2017;106:32–8. https://doi.org/10.1016/j.urology.2017.03.054Researchers demonstrate the successful incorporation of the Timed Up and Go Test as an indicator of patient frailty for potential operative planning in their urologic practice. While there was no difference in frailty measures in patients undergoing operative versus nonoperative management, they acknowledged the role for frailty indices in treatment planning.CrossRefPubMedPubMedCentral

23.

Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489–95. https://doi.org/10.1503/cmaj.050051.CrossRefPubMedPubMedCentral

24.

Amin KA, Lee W, Moskowitz D, Kobashi KC, Lucioni A, Reed MJ, et al. A rapid method to preoperatively assess frailty for older patients with pelvic floor conditions. J Urol. 2020;203:1172–7. https://doi.org/10.1097/JU.0000000000000739.CrossRefPubMed

25.

•• Suskind AM, Quanstrom K, Zhao S, Bridge M, Walter LC, Neuhaus J, et al. Overactive bladder is strongly associated with frailty in older individuals. Urology. 2017;106:26–31. https://doi.org/10.1016/j.urology.2017.03.058This prospective study aimed to elucidate the complex relationship between advanced age, frailty and overactive bladder. They demonstrated that overactive bladder is strongly associated with frailty, as measured in the office with a Timed Up and Go Test, rather than increasing age.CrossRefPubMedPubMedCentral

26.

Omae K, Yamamoto Y, Kurita N, Takeshima T, Naganuma T, Takahashi S, et al. Gait speed and overactive bladder in the healthy community-dwelling super elderly: the Sukagawa Study. Neurourol Urodyn. 2019;38:2324–32. https://doi.org/10.1002/nau.24148.CrossRefPubMed

27.

Wolff GF, Kuchel GA, Smith PP. Overactive bladder in the vulnerable elderly. Res Rep Urol. 2014;6:131–8. https://doi.org/10.2147/RRU.S41843.CrossRefPubMedPubMedCentral

28.

Talley KMC, Wyman JF, Bronas U, Olson-Kellogg BJ, McCarthy TC. Defeating urinary incontinence with exercise training: results of a pilot study in frail older women. J Am Geriatr Soc. 2017;65:1321–7. https://doi.org/10.1111/jgs.14798.CrossRefPubMedPubMedCentral

29.

Jensen J, Ludin-Olsson L, Nyberg L, Gustafson Y. Falls among frail older people in residential care. Scand J Public Health. 2002;30:54–61. https://doi.org/10.1177/14034948020300011201.CrossRefPubMed

30.

Lichetenstein AH, Rasmussen H, Yu WW, Epstein SR, Russell RM. Modified MyPyramid for older adults. J Nutr. 2008;138:5–11. https://doi.org/10.1093/jn/138.1.5.CrossRef

31.

Picetti D, Foster S, Pangle AK, Schrader A, George M, Wei JY, et al. Hydration health literacy in the elderly. Nutr Healthy Aging. 2017;4:227–37. https://doi.org/10.3233/NHA-170026.CrossRefPubMedPubMedCentral

32.

Lindeman RD, Romero LJ, Liang HC, Baumgartner RN, Koehler KM, Garry PJ. Do elderly persons need to be encouraged to drink more fluids? J Gerontol A Biol Sci Med Sci. 2000;55:M361–5. https://doi.org/10.1093/gerona/55.7.m361.CrossRefPubMed

33.

• Suskind AM. The aging overactive bladder: a review of aging-related changes from the brain to the bladder. Curr Bladder Dysfunt Rep. 2017;12:42–7. https://doi.org/10.1007/s11884-017-0406-7The prevalence of overactive bladder increases with age, but the pathophysiology of this relationship is murky. This review article used new functional magnetic resonance imaging (fMRI) data to suggest that OAB development is likely related to the complex multifactorial interaction of physiologic decline in the bladder as well as the brain, ultimately pathologically influencing the micturition reflex.CrossRef

34.

Burgio KL, Locher JL, Goode PS. Combined behavioral and drug therapy for urge incontinence in older women. J Am Geriatr Soc. 2000;48:370–4. https://doi.org/10.1111/j.1532-5415.2000.tb04692.x.CrossRefPubMed

35.

Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Millard RJ, Burcher E. Muscarinic receptor subtypes in human bladder detrusor and nucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol. 2005;144:1089–99. https://doi.org/10.1038/sj.bjp.0706147.CrossRefPubMedPubMedCentral

36.

Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia. JAMA Intern Med. 2019;179:1084–93. https://doi.org/10.1001/jamainternmed.2019.0677.CrossRefPubMedCentral

37.

Perry EK, Kilford L, Lees AJ, Burn DJ, Perry RH. Increased Alzheimer pathology in Parkinson’s disease related to antimuscarinic drugs. Ann Neurol. 2003;54:235–8. https://doi.org/10.1002/ana.10639.CrossRefPubMed

38.

Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong Anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175:401–7. https://doi.org/10.1001/jamainternmed.2014.7663.CrossRefPubMedPubMedCentral

39.

•• Welk B, McArthur E. Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study. BJU Int. 2020;126:183–90. https://doi.org/10.1111/bju.15040This matched retrospective cohort study demonstrated an increased risk of new onset dementia in patients taking an anticholinergic medication when compared to a beta-3 agonist. Notably, this study was conducted in first time users of anticholinergics, seemingly eliminating protocol bias seen in previous studies.CrossRefPubMed

40.

Liu YP, Chien WC, Chung CH, Chang HA, Kao YC, Tzeng NS. Are anticholingergic medications associated with increased risk of dementia and behavioral and psychological symptoms of dementia? A nationwide 15-year follow-up cohort study in Taiwan. Front Pharmacol. 2020;11:30. https://doi.org/10.3389/fphar.2020.00030.CrossRefPubMedPubMedCentral

41.

Kay GG, Abou-Donia MB, Messer WS, Murphy DG, Tsao JW, Ouslander JG. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc. 2005;53:2195–201. https://doi.org/10.1111/j.1532-5415.2005.00537.x.CrossRefPubMed

42.

Geller EJ, Dumond JB, Bowling JM, Khandelwal CM, Wu JM, Busby-Whitehead J, et al. Effect of trospium chloride on cognitive function in women aged 50 and older: a randomized trial. Female Pelvic Med Reconstr Surg. 2017;2017(23):118–23. https://doi.org/10.1097/SPV.0000000000000374.CrossRef

43.

Kosilov K, Kuzina I, Loparev S, Gainullina Y, Kosilova L, Prokofyeva A. Influence of the short-term intake of high doses of solifenacin and trospium on cognitive function and health-related quality of life in older women with urinary incontinence. Int Neurourol J. 2018;22:41–50. https://doi.org/10.5213/inj.1834996.498.CrossRefPubMedPubMedCentral

44.

Wagg A, Dale M, Tretter R, Stow B, Compion G. Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study. Eur Urol. 2013;64:74–81. https://doi.org/10.1016/j.eururo.2013.01.002.CrossRefPubMed

45.

Pagoria D, O’Connor RC, Guralnick ML. Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients. Curr Urol Rep. 2011;12:351–7. https://doi.org/10.1007/s11934-011-0198-9.CrossRefPubMed

46.

Fick DM, Semla TP, Steinman M, Beizer J, Brandt N, Dombrowski R, et al. Updated AGS beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;2019(67):674–94. https://doi.org/10.1111/jgs.15767.CrossRef

47.

Sink KM, Thomas J, Xu H, Craig B, Kritchevsky S, Sands LP. Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes. J Am Geriatr Soc. 2008;56:847–53. https://doi.org/10.1111/j.1532-5415.2008.01681.x.CrossRefPubMedPubMedCentral

48.

Deeks ED. Mirabegron: a review in overactive bladder syndrome. Drugs. 2018;78:833–44. https://doi.org/10.1007/s40265-018-0924-4.CrossRefPubMed

49.

•• Wagg A, Staskin D, Engel E, Herschorn S, Kristy RM, Schermer CR. Efficacy, safety and tolerability of mirabegron in patients aged >65 yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR). Eur Urol. 2020;77:211–20. https://doi.org/10.1016/j.eururo.2019.10.002Researchers examined the safety profile of mirabegron in patients over the age of 65, which is patient population previously unstudied for this medication. Patients reported significant improvement in voiding symptoms with minimal adverse side effects and notably, no change in cognitive impairment.CrossRefPubMed

50.

Herr M, Robine JM, Pinot J, Arvieu JJ, Ankri J. Polypharmacy and frailty: prevalence, relationship and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf. 2015;24:637–46. https://doi.org/10.1002/pds.3772.CrossRefPubMed

51.

Gutierrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero A, Inzitari M, Martinez-Velilla N. The relationship between frailty and polypharmacy in older people: a systematic review. Br J Clin Pharmacol. 2018;84:1432–44. https://doi.org/10.1111/bcp.13590.CrossRefPubMedPubMedCentral

52.

Liao CH, Kuo HC. Increased risk of large post-void residual urine and decreased long-term success rate after intravesical onabotulinumtoxinA injection for refractory idiopathic detrusor overactivity. J Urol. 2013;189:1804–10. https://doi.org/10.1016/j.juro.2012.11.089.CrossRefPubMed

53.

Kuo HC, Liao CH, Chung SD. Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome. Eur Urol. 2010;58:919–26. https://doi.org/10.1016/j.eururo.2010.09.007.CrossRefPubMed

54.

• Greenberg DR, Syan R, Young-Lin N, Comiter CV, Enemchukwu E. Outcomes of sacral nerve stimulation for treatment of refractory overactive bladder among octogenarians. Neuromodulation. 2019;22:738–44. https://doi.org/10.1111/ner.12981This retrospective review is one of the first to demonstrate the efficacy of sacral nerve stimulation (SNS) in patients over the age of 80 with overactive bladder, which is significant as older age is often cited as a reason to avoid this treatment modality.CrossRefPubMed

Title: Treatment of Overactive Bladder in the Frail Patient
Authors: Sage Vincent
Anthony Tokarski
Alana Murphy
Publication date: 01-12-2020
Publisher: Springer US
Keyword: Overactive Bladder
Published in: Current Bladder Dysfunction Reports / Issue 4/2020
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI: https://doi.org/10.1007/s11884-020-00621-0

At a glance: The STEP trials

Springer Medicine

Treatment of Overactive Bladder in the Frail Patient

Abstract

Purpose of Review

Recent Findings

Summary

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 4/2020

The Current Status of Global Urology

Contemporary Landmark Trials Update in the Management of Idiopathic Overactive Bladder

The Necessity of Postoperative Bladder Training by Intermittent Clamping: a Urologist’s View

Review of Current Neurogenic Bladder Best Practices and International Guidelines

Vaginal Yeast Infection

Managing Sphincter Deficiency Stress Urinary Incontinence in the Neurogenic Patient: Diagnosis and Management Strategies